You are here  Home  

Sandercock, P. (UK), MD, FRCP

Department of Clinical Neurosciences, Western General Hospital, University of Edinburgh, UK


Peter Sandercock is Professor and reader in medical neurology at the Department of Clinical Neurosciences at the University of Edinburgh, UK.

Dr Sandercock’s main research interests focus on the treatment, prevention and rehabilitation of stroke. He is especially interested in thrombolysis for acute stroke, and in the use of anticoagulants versus antiplatelet agents for acute ischaemic stroke.

Dr Sandercock was the principal investigator of the second International Stroke Trial (IST-2) to evaluate a neuroprotective compound (619c89), is chairman of the Steering Committee for the third International Stroke Trial (IST3) of thrombolysis in acute stroke and a member of the Trial Steering Committee for the MRC IMAGES trial (of Magnesium, a potentially neuroprotective agent). He is principle investigator in the Oxford Vascular Study (OXVASC).

Dr Sandercock is an editor for the journal ‘Stroke’ and for the Cochrane Database System Review. Further on he is on the list of contributors of several books about stroke and cerebrovascular diseases for example ‘Stroke: a practical guide to management. C P Warlow, M Dennis, J van Gijn, G Hankey, J Bamford, P Sandercock, J Wardlaw. (1996) Blackwells Scientific, Oxford.’

Dr Sandercock has authored and co-authored more than 180 excellent publications on cerebrovascular diseases in journals such as Stroke, Lancet, Archives of Neurology, Cerebrovascular Diseases, the Journal of Neurology, Neurosurgery and Psychiatry, the British Medical Journal, the Journal of Neurology, Neurologia, the New England Journal of Medicine, and Neurology.

  • Can patients be too mild, too severe or too old for thrombolysis?

  • Evidence Based Stroke Medicine: the good, the bad and the ugly – how to assess evidence

  • Evidence-based management and treatment of TIA

  • IST 3: How Does it Change Management?

  • Optimal design for systematic reviews and randomised trials to answer your clinical question

  • What can research in animals tell us about how to treat patients?